{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:46:18Z","timestamp":1791225978332,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81173011"],"award-info":[{"award-number":["81173011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81422044"],"award-info":[{"award-number":["81422044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science & Technology Major Project of China","award":["2012ZX09304004"],"award-info":[{"award-number":["2012ZX09304004"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jconrel.2016.02.043","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T23:16:18Z","timestamp":1456874178000},"page":"9-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":194,"special_numbering":"C","title":["Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways"],"prefix":"10.1016","volume":"228","author":[{"given":"Man","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengnan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.02.043_bb0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm1461","article-title":"Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants","volume":"13","author":"Fischer","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0010","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","volume":"496","author":"Liao","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature13601","article-title":"Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface","volume":"515","author":"Huang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0020","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1021\/nl300027p","article-title":"Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment","volume":"12","author":"Xu","year":"2012","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0025","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1021\/nl404560v","article-title":"A peptide-based nanofibrous hydrogel as a promising DNA nanovector for optimizing the efficacy of HIV vaccine","volume":"14","author":"Tian","year":"2014","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0030","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0035","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/JVI.56.2.628-632.1985","article-title":"In vitro synthesis of an infectious RNA from cDNA clones of human rhinovirus type 14","volume":"56","author":"Mizutani","year":"1985","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0040","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.bbrc.2005.12.105","article-title":"mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with poly (A) chains in cis and in trans for a high protein expression level","volume":"340","author":"Mockey","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0045","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejpb.2008.09.016","article-title":"Current prospects for mRNA gene delivery","volume":"71","author":"Yamamoto","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0050","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1021\/acs.nanolett.5b00570","article-title":"Engineering nanoparticle-coated bacteria as oral DNA vaccines for cancer immunotherapy","volume":"15","author":"Hu","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0055","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/14712598.4.8.1285","article-title":"Messenger RNA-based vaccines","volume":"4","author":"Pascolo","year":"2004","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0060","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1021\/mp200604h","article-title":"Comparison of the gene transfer efficiency of mRNA\/GL67 and pDNA\/GL67 complexes in respiratory cells","volume":"9","author":"Andries","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0065","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2010.10.020","article-title":"mRNA as gene therapeutic: how to control protein expression","volume":"150","author":"Tavernier","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0070","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection","volume":"30","author":"Petsch","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature14053","article-title":"Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations","volume":"517","author":"Deng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0080","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/sj.cgt.7701072","article-title":"mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes","volume":"14","author":"Mockey","year":"2007","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/mt.2012.202","article-title":"Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines","volume":"21","author":"Pollard","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40425-015-0068-y","article-title":"Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I\/IIa study","volume":"3","author":"Kubler","year":"2015","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0095","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist\u00ae; fluenz\u2122)","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.0105-2896.2005.00299.x","article-title":"Bronchus-and nasal-associated lymphoid tissues","volume":"206","author":"Bienenstock","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0105","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/08820131003680369","article-title":"Function of mucosa-associated lymphoid tissue in antibody formation","volume":"39","author":"Brandtzaeg","year":"2010","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0115","series-title":"Optimizing efficacy of mucosal vaccines","author":"Gebril","year":"2012"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/10611860108997935","article-title":"Transport of nanoparticles across the rat nasal mucosa","volume":"9","author":"Brooking","year":"2001","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0125","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1021\/nn5066793","article-title":"pH-responsive Poly(d,l-lactic-co-glycolic acid) nanoparticles with rapid antigen release behavior promote immune response","volume":"9","author":"Liu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0130","doi-asserted-by":"crossref","first-page":"e86-e86","DOI":"10.1093\/nar\/gni085","article-title":"A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids","volume":"33","author":"Read","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0135","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1021\/mp100390w","article-title":"In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles","volume":"8","author":"Su","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0140","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1016\/j.biomaterials.2009.02.050","article-title":"High performance mRNA transfection through carbonate apatite\u2013cationic liposome conjugates","volume":"30","author":"Zohra","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0145","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1021\/mp3003336","article-title":"Internalization of mRNA lipoplexes by dendritic cells","volume":"9","author":"De Haes","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/14760584.2015.986104","article-title":"Lipid-based mRNA vaccine delivery systems","volume":"14","author":"Midoux","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0155","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1038\/srep05128","article-title":"Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity","volume":"4","author":"Phua","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0955-2863(01)00208-X","article-title":"The effect of chitosan and other polycations on tight junction permeability in the human intestinal caco-2 cell line1","volume":"13","author":"Ranaldi","year":"2002","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0165","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jconrel.2010.09.007","article-title":"Delivery of messenger RNA using poly(ethylene imine)-poly(ethylene glycol)-copolymer blends for polyplex formation: biophysical characterization and in vitro transfection properties","volume":"148","author":"Debus","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0169-409X(98)00054-4","article-title":"Cyclodextrins in nasal drug delivery","volume":"36","author":"Merkus","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0378-5173(99)00342-7","article-title":"Safety assessment of selected cyclodextrins \u2014 effect on ciliary activity using a human cell suspension culture model exhibiting in vitro ciliogenesis","volume":"193","author":"Agu","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0180","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/bc049891g","article-title":"Cyclodextrin-modified polyethylenimine polymers for gene delivery","volume":"15","author":"Pun","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0185","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jgm.874","article-title":"Low molecular weight polyethylenimines linked by \u03b2-cyclodextrin for gene transfer into the nervous system","volume":"8","author":"Tang","year":"2006","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-1759(96)00243-8","article-title":"Isolation and characterization of mouse nasal-associated lymphoid tissue","volume":"202","author":"Asanuma","year":"1997","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0195","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1016\/j.biomaterials.2011.07.086","article-title":"Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins","volume":"32","author":"Sonaje","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0200","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1007\/s11095-014-1372-9","article-title":"Enhancement of nasal HIV vaccination with adenoviral vector-based nanocomplexes using mucoadhesive and DC-targeting adjuvants","volume":"31","author":"Jiang","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0205","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1023\/A:1018869601502","article-title":"In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery","volume":"16","author":"Witschi","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00452-X","article-title":"Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery","volume":"208","author":"Foster","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0215","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1021\/bm4000713","article-title":"Ionization behavior of chitosan and chitosan\u2013DNA polyplexes indicate that chitosan has a similar capability to induce a proton-sponge effect as PEI","volume":"14","author":"Richard","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0220","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1023\/B:PHAM.0000003383.86238.d1","article-title":"Poly-l-arginine enhances paracellular permeability via serine\/threonine phosphorylation of ZO-1 and tyrosine dephosphorylation of occludin in rabbit nasal epithelium","volume":"20","author":"Ohtake","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0225","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1074\/jbc.M310175200","article-title":"mRNA is an endogenous ligand for toll-like receptor 3","volume":"279","author":"Karik\u00f3","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CJI.0b013e3181f7dbe8","article-title":"Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity","volume":"34","author":"Fotin-Mleczek","year":"2011","journal-title":"J. Immunother."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jconrel.2013.01.033","article-title":"Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells","volume":"167","author":"Andries","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.02.043_bb0240","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.addr.2005.07.009","article-title":"Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives","volume":"57","author":"Ugwoke","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0245","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.carbpol.2013.08.027","article-title":"Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats","volume":"99","author":"Bshara","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0250","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nbt.2344","article-title":"Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens","volume":"30","author":"Wegmann","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.02.043_bb0255","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.biomaterials.2011.11.068","article-title":"Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization","volume":"33","author":"Wu","year":"2012","journal-title":"Biomaterials"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916301079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916301079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T07:04:43Z","timestamp":1600239883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916301079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":51,"alternative-id":["S0168365916301079"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.02.043","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.02.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}